Resource Library

April 2025 Newsletter

This study examines patient experiences with a digital therapeutic telehealth program for opioid use disorder (OUD) treatment using buprenorphine. Participants reported that telehealth helped overcome many barriers associated with traditional in-person care, such as logistical challenges, financial

Synthetic Drugs: Gender and Age in Thailand 2023 provides the overview of Methamphetamine, Ketamine, and other synthetic drugs situation in Thailand focusing on gender and age involved on both supply and demand.   This survey is sponsored by UNOV and UNODC and supported by Office of the Narcoti

Abtract Abstrak   IMPORTANCE POIN PENTING   Buprenorphine treatment for opioid use disorder (OUD) has more than doubled since 2009. However, current US Food and Drug Administration buprenorphine dosing guidelines are based on studies among people using heroin, prior to the emergence of fen

  Primera reunión regional Latinoamérica y el Caribe del Consorcio Internacional de Universidades para la Reducción de la Demanda de Drogas (ICUDDR) - 17 al 18 Abril 2023, en el aula 103 de la Universidad del Museo Social Argentino (UMSA)- Buenos Aires, Argentina Descr

The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) (https://www.who.int/substance_abuse/activities/assist_v3_english.pdf) makes use of risk categories determined by screening scores to help determine the ideal intervention strategy.  This tool was developed by WHO as a paper

This report describes results of the Training needs Assessment Study of Specialists Who Provide Care to People with Substance Use Disorders in Ukraine, which was perfomed by ITTC Ukraine in 2021.ITTC Ukraine was created in 2021. In order to organize its effective work, it was decided to assess the a

Facing the complicated situation of COVID-19 which makes us realize that our health is extremely important, whether it is our physical health or mental health. With the purpose of counseling and supporting health issues due to COVID-19, a group of experts from Hanoi Medical University, University o

In the complicated and unpredictable context of the COVID-19 epidemic, substance users are facing a lot of problems, not only physically, but also mentally and especially difficulty accessing medical services. These factors easily trigger the relapse or overdose of drugs, leading to severe consequen

Introduction Pendahuluan Despite well-documented benefits of opioid agonist treatment (OAT), there are still many barriers that diminish its potential benefits. Coverage with OAT and needle and syringe programs (NSP) remains poor at the global level, especially in the regions with the largest popula

Booklet from the South Africa - HIV ATTC inaugural launch.